$68.61
arrow_drop_down0.63%Key Stats | |
---|---|
Open | $69.24 |
Prev. Close | $69.05 |
EPS | 1.61 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
LOW | HIGH | |
---|---|---|
Day Range | 66.95 | 69.27 |
52 Week Range | 62.34 | 142.00 |
Ratios | |
---|---|
EPS | 1.61 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
DXCM DEADLINE REMINDER: DexCom, Inc. Investors who Lost Money are Reminded to Contact BFA Law before Upcoming Securities Litigation Deadline (Nasdaq:DXCM)
DXCM Lawsuit Reminder: Robbins LLP Encourages DexCom Inc. Stockholders to Seek Counsel for Class Action Lawsuit
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
DexCom (DXCM) Faces Investor and Analyst Backlash After Revealing Disappointing Growth - Hagens Berman
mHealth Market is expected to reach a revenue of USD 210.8 Bn by 2033, at 12.1% CAGR: Dimension Market Research
Is DexCom a Millionaire-Maker Stock?